Alice Melão,  —

Articles by Alice Melão

MediciNova Launches Phase 2b/3 Trial of Ibudilast for ALS

MediciNova has launched the Phase 2b/3 clinical trial that will explore the potential of ibudilast (MN-166) in patients with amyotrophic lateral sclerosis (ALS). Pending the success of the trial, the collected data will support the submission of a new drug application and the approval of ibudilast…